Your browser doesn't support javascript.
loading
CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.
Shahzad, Khurrum; Fatima, Sameen; Al-Dabet, Moh'd Mohanad; Gadi, Ihsan; Khawaja, Hamzah; Ambreen, Saira; Elwakiel, Ahmed; Klöting, Nora; Blüher, Matthias; Nawroth, Peter P; Mertens, Peter R; Michel, Sven; Jaschinski, Frank; Klar, Richard; Isermann, Berend.
Afiliación
  • Shahzad K; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Fatima S; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Al-Dabet MM; Institute of Experimental Internal Medicine, Department of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • Gadi I; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Khawaja H; Department of Medical Laboratories, American University of Madaba, Amman, Jordan.
  • Ambreen S; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Elwakiel A; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Klöting N; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Blüher M; Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Department of Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Nawroth PP; Helmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum München at the University of Leipzig, Leipzig, Germany.
  • Mertens PR; Helmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum München at the University of Leipzig, Leipzig, Germany.
  • Michel S; Medical Department III, Endocrinology, Nephrology, Rheumatology, University Hospital Leipzig, Leipzig, Germany.
  • Jaschinski F; Internal Medicine I and Clinical Chemistry, German Diabetes Center, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany.
  • Klar R; Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Department of Internal Medicine, Otto-von-Guericke University, Magdeburg, Germany.
  • Isermann B; Secarna Pharmaceuticals GmbH & Co. KG, Planegg, Germany.
J Am Soc Nephrol ; 32(12): 3066-3079, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34479965
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Experimental / Nefropatías Diabéticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Experimental / Nefropatías Diabéticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania